Cargando…

Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a chronic progressive inflammatory disease of the airways, associated with frailty, disability, co-morbidity, and mortality. Individuals with COPD experience increased risk and rates of acute exacerbation as their lung disease worsens. Curr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cowan, Juthaporn, Mulpuru, Sunita, Aaron, Shawn, Alvarez, Gonzalo, Giulivi, Antonio, Corrales-Medina, Vicente, Thiruganasambandamoorthy, Venkatesh, Thavorn, Kednapa, Mallick, Ranjeeta, Cameron, D. William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087014/ https://www.ncbi.nlm.nih.gov/pubmed/30116551 http://dx.doi.org/10.1186/s40814-018-0327-z

Ejemplares similares

A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD
por: Cowan, Juthaporn, et al.
Publicado: (2021)

A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Cowan, Juthaporn, et al.
Publicado: (2015)

Polyvalent Immunoglobulin as a Potential Treatment Option for Patients with Recurrent COPD Exacerbations
por: Unninayar, Dana, et al.
Publicado: (2021)

Complexity in clinical diagnoses of acute exacerbation of chronic obstructive pulmonary disease
por: Pratt, Alexandre J., et al.
Publicado: (2023)

Pulmonary sequelae of SARS-CoV-2 infection and factors associated with persistent abnormal lung function at six months after infection: Prospective cohort study
por: Yazji, Bashour, et al.
Publicado: (2022)

Factors contributing to high-cost hospital care for patients with COPD
por: Mulpuru, Sunita, et al.
Publicado: (2017)

Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting
por: Pease, Christopher, et al.
Publicado: (2021)

Barriers and facilitators to improving patient safety learning systems: a systematic review of qualitative studies and meta-synthesis
por: Mahmoud, Hassan Assem, et al.
Publicado: (2023)

Incidence Rate of Post-Kidney Transplant Infection: A Retrospective Cohort Study Examining Infection Rates at a Large Canadian Multicenter Tertiary-Care Facility
por: Cowan, Juthaporn, et al.
Publicado: (2018)

Risk assessment tools to predict location of discharge and need for supportive services for medical patients after discharge from hospital: a systematic review protocol
por: Kobewka, Daniel M., et al.
Publicado: (2017)

Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry
por: Abadeh, Armin, et al.
Publicado: (2023)

Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations
por: Lin, Chieh-Mo, et al.
Publicado: (2020)

Predicting the need for supportive services after discharged from hospital: a systematic review
por: Kobewka, Daniel M., et al.
Publicado: (2020)

Breathing–swallowing discoordination is associated with frequent exacerbations of COPD
por: Nagami, Shinsuke, et al.
Publicado: (2017)

Antiviral immunity is impaired in COPD patients with frequent exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2019)

Enhancing COVID Rehabilitation with Technology (ECORT): protocol for an open-label, single-site randomized controlled trial evaluating the effectiveness of electronic case management for individuals with persistent COVID-19 symptoms
por: Hatcher, Simon, et al.
Publicado: (2022)

Bioinformatics-based identification of potential microRNA biomarkers in frequent and non-frequent exacerbators of COPD
por: Liu, Xiao, et al.
Publicado: (2018)

Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency
por: Dinh, Tri, et al.
Publicado: (2019)

Predicting frequent COPD exacerbations using primary care data
por: Kerkhof, Marjan, et al.
Publicado: (2015)

Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients
por: Wu, Yao-Kuang, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators
por: Lu, Fang-Ying, et al.
Publicado: (2021)

Levels of immunoglobulin isotypes in serum and respiratory samples of patients with chronic obstructive pulmonary disease: protocol for a systematic review and meta-analysis
por: Unninayar, Dana, et al.
Publicado: (2023)

Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting
por: Scarffe, Andrew D., et al.
Publicado: (2022)

Cutaquig(®) Is Well Tolerated in Immunodeficient Patients Who Did Not Tolerate Other Subcutaneous Immunoglobulin Products
por: Brownlee, Sydney, et al.
Publicado: (2022)

Symptoms, Pulmonary Function, and Functional Capacity Four Months after COVID-19
por: Abdallah, Sara J., et al.
Publicado: (2021)

Protocol for updating a systematic review of randomised controlled trials on the prophylactic use of intravenous immunoglobulin for patients undergoing haematopoietic stem cell transplantation
por: Cowan, Juthaporn, et al.
Publicado: (2015)

Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients
por: Jeong, Suk Hyeon, et al.
Publicado: (2016)

Differences in systemic adaptive immunity contribute to the ‘frequent exacerbator’ COPD phenotype
por: Geerdink, Jasper X., et al.
Publicado: (2016)

Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD
por: Wei, Xia, et al.
Publicado: (2017)

Predicting frequent COPD exacerbations using primary care data [Corrigendum]
Publicado: (2018)

Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study
por: Kim, So Rae, et al.
Publicado: (2023)

COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review
por: Poenaru, Sonia, et al.
Publicado: (2021)

Immunoglobulin abnormalities are frequent in patients with lupus nephritis
por: Cuadrado, M. J., et al.
Publicado: (2019)

Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort
por: Singh, Dave, et al.
Publicado: (2014)

Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients
por: Malinovschi, Andrei, et al.
Publicado: (2014)

Antibody deficiency in patients with frequent exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
por: McCullagh, Brian N., et al.
Publicado: (2017)

Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype
por: Zhao, Dongxing, et al.
Publicado: (2020)

AGR3 Regulates Airway Epithelial Junctions in Patients with Frequent Exacerbations of COPD
por: Ye, Rui, et al.
Publicado: (2021)

Clinical Characterization of the Frequent Exacerbator Phenotype in Asthma
por: Sprio, Andrea Elio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_quhfsc77ftevvq4g2bo1nl6oh3